HTR2A and Parkinson disease: Not evaluated in the context of TBI-elicited behavioral changes, though 2/3rds of TBI patients harbored 5-HT2A autoantibodies, the concentrations of which were correlated with other neurological comorbidities, including Parkinsons’ disease, other dementias, and painful neuropathies [97].